Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway
- 17 December 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 112 (8), 839-846
- https://doi.org/10.1093/jnci/djz220
Abstract
Background We estimated breast cancer (BC) mortality reduction associated with invitations to a nationwide population-based screening program and with changes in treatment. Materials and methods BreastScreen Norway started in 1996 and became nationwide in 2005. It invites women aged 50–69 years to biennial mammographic screening. We retrieved individual-level data for 1 340 333 women from national registries. During 1996–2014 (screening window), women contributed person-years in noninvited and invited periods. We created comparable periods for 1977–1995 (prescreening window) by dividing the follow-up time for each woman into pseudo-noninvited and pseudo-invited periods. We estimated BC mortality for the four periods, using the so-called evaluation model: counting BC deaths in each period for all women diagnosed within the period and counting BC deaths and person-years after screening-age for those diagnosed within screening age. We used a multivariable flexible parametric survival model to estimate hazard ratio (HR) for the effect of invitation and improved treatment. Results Using the regression approach, we found 5818 BC deaths across 16 533 281 person-years. Invitations to screening reduced BC mortality by 20% (HR = 0.80, 95% confidence interval [CI] = 0.70 to 0.91) among women 50 years and older and by 25% (HR = 0.75, 95% CI = 0.65 to 0.86) among screening-aged women. The treatment effect was 23% (HR = 0.77, 95% CI = 0.65 to 0.92) for women 50 years and older and 17% (HR = 0.83, 95% CI = 0.74 to 0.94) for screening-aged women. Conclusion We observed a similar reduction in BC mortality associated with invitations to screening and improvements in treatment during 1977–2014, among women 50 years and older.This publication has 19 references indexed in Scilit:
- Hvorfor er resultater fra organisert mammografiscreening så vanskelig å tolke?Tidsskrift for Den norske legeforening, 2014
- Real and artificial controversies in breast cancer screeningBreast Cancer Management, 2013
- Strategies for obtaining unpublished drug trial data: a qualitative interview studySystematic Reviews, 2013
- The benefits and harms of breast cancer screening: an independent reviewThe Lancet, 2012
- Breast cancer mortality in Norway after the introduction of mammography screeningInternational Journal of Cancer, 2012
- Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 DecadesRadiology, 2011
- Effect of Screening Mammography on Breast-Cancer Mortality in NorwayThe New England Journal of Medicine, 2010
- Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timelinessEuropean Journal of Cancer, 2009
- Effect of Screening and Adjuvant Therapy on Mortality from Breast CancerThe New England Journal of Medicine, 2005
- Long-term effects of mammography screening: updated overview of the Swedish randomised trialsThe Lancet, 2002